Stay updated on Brentuximab Vedotin ± Nivolumab in CD30+ Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Brentuximab Vedotin ± Nivolumab in CD30+ Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Brentuximab Vedotin ± Nivolumab in CD30+ Lymphoma Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The update shows Revision: v3.3.2 replacing v3.3.1 with no substantive changes to the study details or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T17:46:23.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Footer shows revision updated from v3.2.0 to v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T14:51:56.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The page-level notice about government funding and NIH operating status has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T07:15:05.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    There are no additions or deletions between the two screenshots. The page content and study details appear unchanged.
    Difference
    0.4%
    Check dated 2025-11-03T01:25:50.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Core content updated with a government-status notice and a new software version (v3.2.0); older version tag (v3.1.0) removed.
    Difference
    4%
    Check dated 2025-10-05T10:35:04.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Version bump from v3.0.2 to v3.1.0. This signals a software update; no other content changes are indicated.
    Difference
    0.1%
    Check dated 2025-09-28T03:22:54.000Z thumbnail image

Stay in the know with updates to Brentuximab Vedotin ± Nivolumab in CD30+ Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Brentuximab Vedotin ± Nivolumab in CD30+ Lymphoma Clinical Trial page.